| 摘要 |
The present invention refers to chemical compounds of formula (I) as well as pharmaceutically usable salts, solvates and esters thereof, wherein R1 to 44 , A1, A2 m and n have the significance given in claim 1. They can be used in t he form of pharmaceutically preparations for the treatment or prevention of disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
|
| 申请人 |
F. HOFFMANN-LA ROCHE AG;VERNALIS RESEARCH LIMITED |
发明人 |
PRATT, ROBERT MARK;BENTLEY, JONATHAN MARK;ADAMS, DAVID REGINALD;STALDER, HENRI;SPECKLIN, JEAN-LUC;NETTEKOVEN, MATTHIAS HEINRICH;WILKINSON, KERRY;DAWSON, CLAIRE ELIZABETH;MIZRAHI, JACQUES;GEORGE, ASHLEY ROGER;DAVIDSON, JAMES EDWARD PAUL;ROFFEY, JONATHAN RICHARD ANTHONY;MANSELL, HOWARD LANGHAM;ROEVER, STEPHAN;MATTEI, PATRIZIO |
